Cargando…
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
Trastuzumab (TZMB) is widely used as first line therapy for breast cancer (BC) patients overexpressing human epidermal growth factor receptor 2 (HER2). Despite its clinical benefits, many patients suffer from primary or secondary resistance to this drug within one year. As diverse molecular mechanis...
Autores principales: | Hwang, Soo-Yeon, Choi, Seul-Ki, Seo, Seung Hee, Jo, Hyunji, Shin, Jae-Ho, Na, Younghwa, Lee, Yun-Sil, Kwon, Youngjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352409/ https://www.ncbi.nlm.nih.gov/pubmed/32545363 http://dx.doi.org/10.3390/cancers12061540 |
Ejemplares similares
-
Sensitization of lung cancer cells by altered dimerization of HSP27
por: Choi, Byeol, et al.
Publicado: (2017) -
Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules
por: Kim, Jee Hye, et al.
Publicado: (2016) -
Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 Dimers
por: Yoo, Hawon, et al.
Publicado: (2021) -
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations
por: Choi, Seul-Ki, et al.
Publicado: (2022) -
The miR-15b-Smurf2-HSP27 axis promotes pulmonary fibrosis
por: Jeon, Seulgi, et al.
Publicado: (2023)